To include your compound in the COVID-19 Resource Center, submit it here.

Bavituximab: Phase Ib data

An open-label, dose-escalation, U.S. Phase Ib trial in 27 patients co-infected with chronic

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE